Skip to main content
. 2022 Dec 12;26(1):27–38. doi: 10.1038/s41593-022-01207-1

Extended Data Fig. 5. Cas13d/CAGEX leads to partial reversal of striatum-specific HD disease markers in Q175/+ mice.

Extended Data Fig. 5

a-o. Quantification of striatum-specific HD disease markers via quantitative PCR. CAGEX (one-way ANOVA, Tukey Posthoc Test,, **p = 0.046, (b)*** p = 0.0003, (e)*** p = 0.0002, ****p < 0.0001; n = 3 per experimental group).

Source data